GL1X · GenesisL1 explorer

Research workbench

X-ray crystal structure of the HIV protease complex with L- 700,417, an inhibitor with pseudo C2 symmetry

Analyse X-ray crystal structure of the HIV protease complex with L- 700,417, an… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4PHV
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
UniProt
P12497
Ligands
VAC
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 proteaseprotein997% helix, 56% strandP12497

Ligands and binding sites

  • VAC · N,N-bis(2-hydroxy-1-indanyl)-2,6- diphenylmethyl-4-hydroxy-1,7-heptandiamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13510.710.8339VAC

Interfaces

1 interface between chains.

  • A–B · 1849 Ų buried · 41 hydrogen bonds · protein-protein

Compared structures

  • 4PHV · X-ray crystal structure of the HIV protease complex with L-700,417, an inhibitor with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.